mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0008 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |